CoChat

Effects of SGLT2 inhibitors on stroke and its subtypes in patients with type 2 diabetes: a systematic review and meta-analysis.

Open access

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Abstract

Sodium-glucose cotransporter 2 (SGLT2) inhibitors have shown impressive effects in reducing major vascular events in several randomized controlled trials (RCTs). The purpose of this study was to perform a meta-analysis to evaluate the effect of SGLT2 inhibitors on the risk of stroke and its subtypes. All data from prospective RCTs up to 20 October 2020 involving SGLT2 inhibitors that reported stroke events as the primary endpoint or safety in subjects with type 2 diabetes were subjected to meta-analysis. Five eligible RCTs (EMPA-REG, CANVAS, DECLARE-TIMI 58, CREDENCE and VERTIS CV) involving 46,969 participants were included. Pooled analysis of the RCTs showed no significant effect of SGLT2 inhibitors on total stroke [risk ratio (RR) = 0.95; 95% confidence interval (CI) 0.79–1.13, P = 0.585]. Subgroup analysis indicated that SGLT2 inhibitors had no significant effect against fatal stroke, non-fatal stroke, ischemic stroke or transient ischemic attack. When only hemorrhagic stroke was included, SGLT2 inhibitors were associated with a significant 50% reduction compared with placebo (RR = 0.49, 95% CI 0.30–0.82, P = 0.007). This meta-analysis shows that SGLT2 inhibitors have a neutral effect on the risk of stroke and its subtypes but a potential protective effect against hemorrhagic stroke.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-021-94945-4

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Flow chart showing selection of studies for meta-analysis.
Figure 1 Flow chart showing selection of studies for meta-analysis.CC BY · PubMed Central
Figure 2 Forest plots for meta-analysis of the effects of SGLT2 inhibitors on stroke outcomes: (A) non-fatal stroke; (B) fatal stroke and (C) total stroke. Summary effects for all drugs were obtained from a random-effect model.
Figure 2 Forest plots for meta-analysis of the effects of SGLT2 inhibitors on stroke outcomes: (A) non-fatal stroke; (B) fatal stroke and (C) total stroke. Summary effects for all drugs were obtained from a random-effect model.CC BY · PubMed Central
Figure 3 Forest plots for meta-analysis of the effects of SGLT2 inhibitors on stroke subtype: (A) ischemic stroke; (B) hemorrhagic stroke and (C) transient ischemic attack (TIA). Summary of effects for all drugs were obtained from a random-effect model.
Figure 3 Forest plots for meta-analysis of the effects of SGLT2 inhibitors on stroke subtype: (A) ischemic stroke; (B) hemorrhagic stroke and (C) transient ischemic attack (TIA). Summary of effects for all drugs were obtained from a random-effect model.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 38 references

Cited by

See all 113

Metadata

Authors
Tsai, W.-H., Chuang, S.-M., Liu, S.-C., Lee, C.-C., Chien, M.-N., Leung, C.-H., Liu, S.-J., & Shih, H.-M.
Affiliations
  • Mackay Memorial Hospital (TW)
  • National Taiwan University (TW)
Corresponding author
Chuang, Shih-Ming
Venue
Scientific Reports
Published
2021-07-28
Volume
11
Issue
1
Pages
15364-15364
ISSN
2045-2322 (ISSN-L)
OpenAlex
W3186786961
Cited by
113
References
38
Citations by year
2026: 21 · 2025: 18 · 2024: 30 · 2023: 21 · 2022: 20 · 2021: 3
FWCI
2.84
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Tamkang University Institutional Repository (TKUIR) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Mackay Memorial Hospital
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
Keywords
SGLT2 inhibitors, stroke, hemorrhagic stroke, ischemic stroke, transient ischemic attack, type 2 diabetes, drug safety, EMPA-REG, Canva, DECLARE-TIMI 58, degrees of belief
MeSH terms
Sodium-Glucose Transporter 2 Inhibitors, Hemorrhagic Stroke, Diabetes Mellitus, Type 2, Humans, Randomized Controlled Trials as Topic, Risk Assessment, Sodium-Glucose Transporter 2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of SGLT2 inhibitors on stroke and its subtypes in patients with type 2 diabetes: a systematic review and meta-analysis. https://app.cochat.ai/papers/10.1038/s41598-021-94945-4
The paper
Tsai, W.-H., Chuang, S.-M., Liu, S.-C., Lee, C.-C., Chien, M.-N., Leung, C.-H., Liu, S.-J., & Shih, H.-M. (2021). Effects of SGLT2 inhibitors on stroke and its subtypes in patients with type 2 diabetes: a systematic review and meta-analysis. Scientific Reports. https://doi.org/10.1038/s41598-021-94945-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.